Surgical & Medical Instruments & Apparatus
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Sector
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|
Net Margin | 2.9% | 2.4% | -9.3% | -37% | -22% | -24% |
ROA | - | 5.1% | -4.6% | -24% | -11% | -13% |
ROE | 14% | 8.8% | -7.1% | -48% | -27% | -33% |
The average Net Margin over the past 5 years is -22.11%.
The trend of Net Margin over the past 5 years is -.
The average ROA over the past 5 years is -10.95%.
The trend of ROA over the past 5 years is -.
The average ROE over the past 5 years is -26.92%.
The trend of ROE over the past 5 years is -.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM | ||||
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | - | - | -0.48 | - | - | - | ||||
Debt Equity | - | 0.28 | 0.05 | 0.33 | 0.65 | 0.70 | ||||
MIN | ||||||||||
Graham Stability | - | - | - | - | - | - |
The Debt/FCF trailing twelve month is -.
The trend of Debt/FCF over the past 5 years is -.
Graham’s Stability measure stands at -.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 12-2020 | 12-2022 | Trend |
---|---|---|---|
Revenue | 25% | 19% | 3.5% |
Net Income | - | - | 0% |
Stockholders Equity | 80% | 26% | -58% |
FCF | - | - | - |
The Revenue CAGR over the past 5 years is -.
The trend of Revenue growth rate over the past 5 years is +3.48%.
The Earnings CAGR over the past 5 years is -.
The trend of Earnings growth rate over the past 5 years is 0%.
The Equity CAGR over the past 5 years is -.
The trend of Equity growth rate over the past 5 years is -57.71%.
The FCF CAGR over the past 5 years is -.
The trend of FCF growth rate over the past 5 years is -.